sellWeak10b5-1 plan
Stephen K. Brannan sold $889k of KRTX
Chief Medical Officer at Karuna Therapeutics, Inc.. 5,000 shares at an average of $177.85, traded Nov 8, 2023, filed Nov 13, 2023.
Warning score
8Value
$889k
5,000 shares
Holdings after
33,650
-13% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +23Trade size$889k at market
- +5Share of holdings soldSold 13% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-23-063121, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 8, 2023 | MOption exercise Common Stock10b5-1 | +2,500 | $5.45 | $14k | 33,650 | Nov 13, 2023 |
| Nov 8, 2023 | MOption exercise Common Stock10b5-1 | +5,000 | $131.64 | $658k | 38,650 | Nov 13, 2023 |
| Nov 8, 2023 | SOpen-market sale Common Stock10b5-1 | -1,281 | $174.11 | $223k | 37,369 | Nov 13, 2023 |
| Nov 8, 2023 | SOpen-market sale Common Stock10b5-1 | -401 | $175.69 | $70k | 36,968 | Nov 13, 2023 |
| Nov 8, 2023 | SOpen-market sale Common Stock10b5-1 | -265 | $177.14 | $47k | 36,703 | Nov 13, 2023 |
| Nov 8, 2023 | SOpen-market sale Common Stock10b5-1 | -808 | $178.90 | $145k | 35,895 | Nov 13, 2023 |
| Nov 8, 2023 | SOpen-market sale Common Stock10b5-1 | -2,245 | $180.08 | $404k | 33,650 | Nov 13, 2023 |
| Nov 8, 2023 | MOption exercise Option (right to buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 14,677 | Nov 13, 2023 |
| Nov 8, 2023 | MOption exercise Option (right to buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 31,350 | Nov 13, 2023 |
Related signals
Other insiders at Karuna Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.6M 5,000 shares | -11% | |
| 10Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.6M 5,000 shares | -11% | |
| 15Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $4.8M 15,000 shares | -28% | |
| 10Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $2.0M 10,000 shares | -22% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.